Publications
The GM stacked gene revolution: A biosafety nightmare PDF Print option in slimbox / lytebox? (info) E-mail
Thursday, 04 March 2010 10:01

Stacked GMOs are those containing more than one gene genetically engineered into a crop plant. A controversial stacked GMO, Smarstax containing 8 such genetically engineered genes, was commercially approved in the US, Canada, Japan and South Korea during 2009. Stacked gene varieties are highly complex, posing new biosafety risks that outpace the capacity of regulatory systems. Since 2005 theglobal area under stackedGMOs has nearly trebled, to just under 30 million ha. If thisrateof adoption continues,an area the size of Mozambique could be planted with them by 2015.Their research, development and ownership is also dominated by a handful of the world's largest biotech companies. This drive for stacked GMOs is ostensibly for 'climate ready' crops to improve 'food security' and 'climate adaptation'. However, the increased profit margins of stacked GMOs, and the opportunities they will afford for the unprecedented patenting of lifeforms hints at an altogether more insidious motivation.

Download 400.40 Kb

 
GM Food aid: Africa denied choice once again? PDF Print option in slimbox / lytebox? (info) E-mail
Sunday, 07 February 2010 13:38

Controversy over genetically modified (GM) food aid arose in 2000 in Latin America, and Asia, and exploded in 2002, when several southern African countries refused GM food aid during a food crisis. Now, in 2004 the controversy has erupted again after Sudan and Angola imposed restrictions over GM food aid. Food aid has been heavily criticized in the last fifty years, because it serves the interests of certain countries, particularly the US Government, as a tool to inter alia facilitate export surpluses and/or capture new markets. The use of GM food aid by the US has added a new dimension to the debate, because the provision of GM food aid is seen as providing an important back- door entry point for the introduction of genetically modified organism (GMOs) in developing countries.

Download 400.22 Kb

 
Bilateral biosafety bullies: How corporations use bilateral trade channels to weaken biotech regulations PDF Print option in slimbox / lytebox? (info) E-mail
Sunday, 07 February 2010 13:17

Across the world, the use of bilateral trade instruments to prise open markets for genetically modified (GM) crops is escalating. To expand business overseas, the biotech industry needs stronger intellectual property rules and weaker biosafety standards. Bilateral trade deals are an effective way to do this. This report looks specifically at how the world's grain and oilseed traders, who account for the bulk of the world's GM crop production and trade today, use bilateral trade channels to prevent countries from building strong biosafety regulatory environments.

Download

 
Alliance for a Green Revolution in Africa: Turning Africa into a repository for failed agricultural technologies PDF Print option in slimbox / lytebox? (info) E-mail
Sunday, 07 February 2010 13:10

The 'new' Green Revolution push in Africa is directed squarely at increasing agricultural production as the continent's most fundamental development priority. The most visible actor in the Green Revolution onslaught is the Alliance for a Green Revolution in Africa (AGRA), a partnership between the Rockefeller Foundation and the Bill and Melinda Gates Foundation. Despite initial successes in increasing output in Asia and Latin America, the Green Revolutions in those respective continents have nevertheless been criticized for their environmental, nutritional and micro-economic impacts. In light of these disparate findings on the various impacts of the Green Revolution, the wholesale adoption of its methods on the African continent would appear miss-informed.

Download 1.33 Mb

 
The status of Genetically Modified (GM) pharmaceutical crop research in South Africa PDF Print option in slimbox / lytebox? (info) E-mail
Sunday, 07 February 2010 11:45

Genetically modified (GM) pharmaceutical crops are crops which have been genetically engineered / modified to produce pharmaceuticals. These pharmaceuticals can be vaccines, anti-bodies or therapeutic proteins. Pharma-crops (as they are known) are a contested and little-known terrain, with remarkable benefits beingclaimed for them in South Africa. Other voices ask about the contamination of the food supply and the environment, and the social costs of this technology. Following our own research into on the issue the African Centre for Biosafety (ACB) contends that further research is needed into potential risks to human health and the food chain, and that the outcomes of this need to be kept in the public domain.

Download 135.25 Kb

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 9 of 16

Spread the word!




Newsletters

Join our Mailing Lists  


Recent publications